Literature DB >> 23543089

Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology.

Waleed Al-hamoudi1, Safiyya Ali, Bassem Hegab, Hussien Elsiesy, Almoutaz Hashim, Mohammed Al-Sofayan, Hatem Khalaf, Hamad Al-Bahili, Nasser Al-Masri, Mohammed Al-Sebayel, Dieter Broering, Ayman Abdo, Saleh Alqahtani, Faisal Abaalkhail.   

Abstract

BACKGROUND: Recently, the upper limits of normal (ULN) for alanine-aminotransferase (ALT) has been recommended to be lowered to ≤ 30 U/l in men and ≤ 19 U/l in women. AIM: To evaluate the ALT concentrations in a healthy Middle Eastern population with biopsy-proven normal liver tissue.
METHODS: ALT values were calculated from 175 consecutive Saudi potential living liver donors who underwent a liver biopsy as part of a stepwise pretransplant workup.
RESULTS: The mean age of the 110 potential donors with normal liver histology was 27 ± 6.2 years for men and 38.6 ± 7.1 years for women. The mean body mass index (BMI) levels were 23.0 ± 3.5 kg/m(2) for men and 24.7 ± 3.25 kg/m(2) for women, and the ALT levels were higher in male patients (22.6 ± 9 vs. 16.4 U/l ± 8, p value = 0.003). Multivariate linear regression showed that BMI and sex were independent variables that were positively associated with the levels of ALT (p < 0.0001). Moreover, when we analyzed donors according to the Prati criteria, 63 (36.0 %) of the individuals were classified into this subgroup. The mean ALT concentration was 12.9 U/l ± 4.5 in women and 19.7 U/l ± 6.9 in men, and these values were significantly lower than those obtained from subjects who did not fit the Prati criteria (19.4 U/l ± 1.8, p = 0.04 for women and 29.0 U/l ± 12.1, p = <0.0001 for men). Thus, we calculated healthy ALT values of 33 IU/l for men and 22 IU/l for women.
CONCLUSIONS: The ULN for ALT levels in Middle Eastern populations should be lowered, including separate values for males and females. Furthermore, metabolic parameters were shown to have a significant effect on ALT levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543089     DOI: 10.1007/s10620-013-2659-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Alanine aminotransferase levels: what's normal?

Authors:  Marshall M Kaplan
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

3.  Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

Authors:  A Piton; T Poynard; F Imbert-Bismut; L Khalil; J Delattre; E Pelissier; N Sansonetti; P Opolon
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

4.  Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C.

Authors:  Faisal M Sanai; Ahmed Helmy; Cheryl Dale; Hamad Al-Ashgar; Ayman A Abdo; Kazuhiro Katada; Hadeel AlMana; Mayssa Saadeh; Hussa Al-Hussaini; Mohammed AlQuaiz; Ahmed Hashem; Khalid AlSwat; Khalid I Bzeizi; Paul J Marotta
Journal:  Liver Int       Date:  2011-05-31       Impact factor: 5.828

5.  Study of serum alanine-aminotransferase levels in blood donors in Spain.

Authors:  M Lozano; J Cid; J L Bedini; R Mazzara; N Gimenez; E Mas; A Ballesta; A Ordinas
Journal:  Haematologica       Date:  1998-03       Impact factor: 9.941

6.  Obesity in Saudi Arabia.

Authors:  Mansour M Al-Nozha; Yaqoub Y Al-Mazrou; Mohammed A Al-Maatouq; Mohammed R Arafah; Mohamed Z Khalil; Nazeer B Khan; Khalid Al-Marzouki; Moheeb A Abdullah; Akram H Al-Khadra; Saad S Al-Harthi; Maie S Al-Shahid; Abdulellah Al-Mobeireek; Mohmmed S Nouh
Journal:  Saudi Med J       Date:  2005-05       Impact factor: 1.484

7.  Diabetes mellitus in Saudi Arabia.

Authors:  Mansour M Al-Nozha; Mohammed A Al-Maatouq; Yaqoub Y Al-Mazrou; Saad S Al-Harthi; Mohammed R Arafah; Mohamed Z Khalil; Nazeer B Khan; Akram Al-Khadra; Khalid Al-Marzouki; Mohammed S Nouh; Moheeb Abdullah; Omer Attas; Maie S Al-Shahid; Abdulellah Al-Mobeireek
Journal:  Saudi Med J       Date:  2004-11       Impact factor: 1.484

8.  Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors.

Authors:  Mehdi Mohamadnejad; Akram Pourshams; Reza Malekzadeh; Ashraf Mohamadkhani; Afsaneh Rajabiani; Ali Ali Asgari; Seyed Meysam Alimohamadi; Hadi Razjooyan; Mansooreh Mamar-Abadi
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management.

Authors:  A Y el-Hassan; E M Ibrahim; F A al-Mulhim; A A Nabhan; M Y Chammas
Journal:  Br J Radiol       Date:  1992-09       Impact factor: 3.039

Review 10.  A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

Authors:  Emmet B Keeffe; Douglas T Dieterich; Steven-Huy B Han; Ira M Jacobson; Paul Martin; Eugene R Schiff; Hillel Tobias
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-23       Impact factor: 11.382

View more
  12 in total

1.  Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males.

Authors:  Shaneez Najmy; Ajay Duseja; Arnab Pal; Suchet Sachdev; Rati R Sharma; Neelam Marwah; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2018-06-21

2.  Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery.

Authors:  Rakan I Nazer; Mohammed F Abalhassan; Khalid A Alburikan
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

3.  Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study.

Authors:  Coskun Ozer Demirtas; Caglayan Keklikkiran; Ilkay Ergenc; Buket Erturk Sengel; Gunes Eskidemir; Ismail Cinel; Zekaver Odabasi; Volkan Korten; Yusuf Yilmaz
Journal:  Int J Clin Pract       Date:  2021-05-29       Impact factor: 3.149

Review 4.  Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.

Authors:  Zhengtao Liu; Huaijun Ning; Shuping Que; Linlin Wang; Xue Qin; Tao Peng
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

5.  Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.

Authors:  Setor K Kunutsor; Dorothy Seddoh
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

6.  Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center.

Authors:  Nasir Fakhar; Saman Nikeghbalian; Kourosh Kazemi; Ali Reza Shamsayeefar; Siavash Gholami; Amir Kasraianfard; Seyed Ali Malek-Hosseini
Journal:  Hepat Mon       Date:  2016-10-08       Impact factor: 0.660

7.  Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Ming Gao; Yi Cheng; Yang Zheng; Weihua Zhang; Lin Wang; Ling Qin
Journal:  BMC Cardiovasc Disord       Date:  2017-01-28       Impact factor: 2.298

8.  Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.

Authors:  Julia Kälsch; Lars P Bechmann; Dominik Heider; Jan Best; Paul Manka; Hagen Kälsch; Jan-Peter Sowa; Susanne Moebus; Uta Slomiany; Karl-Heinz Jöckel; Raimund Erbel; Guido Gerken; Ali Canbay
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

9.  SASLT practice guidelines for the management of hepatitis B virus.

Authors:  Faisal Abaalkhail; Hussien Elsiesy; Ahmed AlOmair; Mohammed Y Alghamdi; Abduljaleel Alalwan; Nasser AlMasri; Waleed Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485

Review 10.  Alanine aminotransferase-old biomarker and new concept: a review.

Authors:  Zhengtao Liu; Shuping Que; Jing Xu; Tao Peng
Journal:  Int J Med Sci       Date:  2014-06-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.